Suchergebnisse - "Hackshaw, Allan"

PubPharm (248)

1

Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer

enthalten in: Cancer discovery | 2024

von Enfield, K. | Colliver, E. | Lee, C. | +32

2

Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening : An Observational Study Examining the Outcomes of CHEST Expert Panel Recommendations

enthalten in: Chest | 2024

von Creamer, A. | Horst, C. | Dickson, J. | +18

3

The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma

enthalten in: Nature cancer | 2024

von Pan, X. | AbdulJabbar, K. | Coelho-Lima, J. | +117

4

Health State Utilities Associated with False-Positive Cancer Screening Results

enthalten in: PharmacoEconomics - open | 2024

von Matza, L. | Howell, T. | Fung, E. | +6

5

Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting

enthalten in: JCO precision oncology | 2024

von Hackshaw, A. | Fajardo, O. | Dafni, U. | +6

6

CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL

enthalten in: Blood | 2024

von Ghorashian, S. | Lucchini, G. | Richardson, R. | +39

CommentIn: Blood. 2024 Jan 11;143(2):97-98. - PMID 38206641

7

Clouds across the new dawn for clinical, diagnostic and biological data : accelerating the development, delivery and uptake of personalized medicine

enthalten in: Diagnosis (Berlin, Germany) | 2023

von Horgan, D. | Capoluongo, E. | Dube, F. | +10

8

Dying To Find Out : The Cost of Time at the Dawn of the Multicancer Early Detection Era

enthalten in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology | 2023

von Klein, E. | Madhavan, S. | Beer, T. | +4

9

Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort

enthalten in: BMJ open respiratory research | 2023

von Tisi, S. | Creamer, A. | Dickson, J. | +105

10

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

enthalten in: Nature medicine | 2023

von Karasaki, T. | Moore, D. | Veeriah, S. | +150

CommentIn: Nat Med. 2023 Apr;29(4):795-796. - PMID 37045998

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]